Wnt/beta-catenin and PI3K/Akt/mTOR signaling pathways in glioblastoma: two main targets for drug design: a review

SH Shahcheraghi, V Tchokonte-Nana… - Current …, 2020 - ingentaconnect.com
Glioblastoma (GBM) is the most common and malignant astrocytic glioma, accounting for
about 90% of all brain tumors with poor prognosis. Despite recent advances in …
被引用次数：97 相关文章

[引用][C] 1. Wnt/beta-catenin and PI3K/Akt/mTOR Signaling Pathways in Glioblastoma: Two Main Targets for Drug Design: A Review

SH Shahcheraghi - spandidos-publications.com
[PDF] researchgate.net

[PDF][PDF] Wnt/beta-catenin and PI3K/Akt/mTOR Signaling Pathways in Glioblastoma: Two Main Targets for Drug Design: A Review

SH Shahcheraghi, V Tchokonte-Nana… - Current …, 2020 - researchgate.net
Glioblastoma (GBM) is the most common and malignant astrocytic glioma, accounting for
about 90% of all brain tumors with poor prognosis. Despite recent advances in …

Wnt/beta-catenin and PI3K/Akt/mTOR Signaling Pathways in Glioblastoma: Two Main Targets for Drug Design: A Review

SH Shahcheraghi… - Current …, 2020 - pubmed.ncbi.nlm.nih.gov
Glioblastoma (GBM) is the most common and malignant astrocytic glioma, accounting for
about 90% of all brain tumors with poor prognosis. Despite recent advances in …

Wnt/beta-catenin and PI3K/Akt/mTOR Signaling Pathways in Glioblastoma: Two Main Targets for Drug Design: A Review.

SH Shahcheraghi, V Tchokonte-Nana… - Current …, 2020 - europepmc.org
Glioblastoma (GBM) is the most common and malignant astrocytic glioma, accounting for
about 90% of all brain tumors with poor prognosis. Despite recent advances in …